AAPL323.85-3.89 (-1.19%) ▼|ABBV253.46-2.65 (-1.03%) ▼|ABT100.82+1.15 (+1.15%) ▲|ACN139.77-1.10 (-0.78%) ▼|ADBE220.19-6.98 (-3.07%) ▼|AMAT560.42-4.13 (-0.73%) ▼|AMD553.93+9.50 (+1.74%) ▲|AMGN367.44+1.20 (+0.33%) ▲|AMT166.14+2.75 (+1.68%) ▲|AMZN242.86-4.69 (-1.89%) ▼|AVGO396.13+9.63 (+2.49%) ▲|AXP348.86-1.94 (-0.55%) ▼|BA209.04+4.24 (+2.07%) ▲|BAC61.61+0.39 (+0.63%) ▲|BKNG179.21-0.19 (-0.11%) ▼|BLK1,044.79+6.55 (+0.63%) ▲|BMY60.84-0.10 (-0.16%) ▼|BNY159.81+0.92 (+0.58%) ▲|BRK-B489.28-0.37 (-0.08%) ▼|C132.83-0.01 (-0.01%) ▼|CAT898.25+8.28 (+0.93%) ▲|CL91.90+1.40 (+1.55%) ▲|CMCSA23.67-0.14 (-0.60%) ▼|COF201.62-4.60 (-2.23%) ▼|COP119.28+1.78 (+1.51%) ▲|COST924.51-4.72 (-0.51%) ▼|CRM162.70-7.36 (-4.33%) ▼|CSCO112.68+0.50 (+0.45%) ▲|CVS109.65-0.96 (-0.86%) ▼|CVX192.90+1.83 (+0.96%) ▲|DE608.21+21.33 (+3.63%) ▲|DHR177.48-1.53 (-0.85%) ▼|DIS96.47+0.33 (+0.34%) ▲|DUK127.86+1.95 (+1.55%) ▲|EMR139.90+0.64 (+0.46%) ▲|FDX319.12+3.93 (+1.25%) ▲|GD372.94+5.21 (+1.42%) ▲|GE341.95+1.25 (+0.37%) ▲|GEV993.30-85.51 (-7.93%) ▼|GILD131.50+1.22 (+0.94%) ▲|GM82.09+2.57 (+3.23%) ▲|GOOG345.87-0.32 (-0.09%) ▼|GOOGL346.53-0.62 (-0.18%) ▼|GS1,095.69+10.13 (+0.93%) ▲|HD332.81+1.21 (+0.36%) ▲|HON232.25+2.39 (+1.04%) ▲|IBM205.66-4.85 (-2.30%) ▼|INTC104.00-1.46 (-1.38%) ▼|INTU285.60-4.32 (-1.49%) ▼|ISRG343.74-6.33 (-1.81%) ▼|JNJ254.66+4.05 (+1.61%) ▲|JPM347.31+2.08 (+0.60%) ▲|KO82.55+0.58 (+0.70%) ▲|LIN510.57+5.54 (+1.10%) ▲|LLY1,163.58-11.84 (-1.01%) ▼|LMT516.18+9.09 (+1.79%) ▲|LOW204.00+1.74 (+0.86%) ▲|LRCX321.50-0.50 (-0.16%) ▼|MA533.26-5.04 (-0.94%) ▼|MCD264.20+0.29 (+0.11%) ▲|MDLZ60.82+0.96 (+1.60%) ▲|MDT81.82-0.54 (-0.65%) ▼|META626.35-17.46 (-2.71%) ▼|MMM170.45-0.32 (-0.18%) ▼|MO72.65-0.34 (-0.47%) ▼|MRK127.80+1.54 (+1.22%) ▲|MS218.35+1.95 (+0.90%) ▲|MSFT387.97-9.78 (-2.46%) ▼|MU971.29+0.47 (+0.05%) ▲|NEE89.60+1.67 (+1.90%) ▲|NFLX69.26+0.59 (+0.86%) ▲|NKE41.96-1.00 (-2.33%) ▼|NOW95.26-6.80 (-6.66%) ▼|NVDA213.69+6.40 (+3.09%) ▲|ORCL125.01-2.04 (-1.61%) ▼|PEP136.07+1.07 (+0.79%) ▲|PFE24.93-0.02 (-0.06%) ▼|PG149.76+1.66 (+1.12%) ▲|PLTR123.84-8.82 (-6.65%) ▼|PM192.80+4.76 (+2.53%) ▲|QCOM176.03+2.53 (+1.46%) ▲|RTX194.83+1.16 (+0.60%) ▲|SBUX104.17-0.28 (-0.27%) ▼|SCHW100.33+0.37 (+0.37%) ▲|SO95.54+1.69 (+1.80%) ▲|SPG226.82+0.03 (+0.01%) ▲|T23.03+0.77 (+3.44%) ▲|TMO524.26+0.80 (+0.15%) ▲|TMUS191.92+1.15 (+0.60%) ▲|TSLA375.83-3.11 (-0.82%) ▼|TXN294.06+2.76 (+0.95%) ▲|UBER70.45-1.10 (-1.54%) ▼|UNH434.68-1.67 (-0.38%) ▼|UNP293.46+0.33 (+0.11%) ▲|UPS116.44+0.10 (+0.09%) ▲|USB64.07+0.36 (+0.56%) ▲|V354.01-1.81 (-0.51%) ▼|VZ44.46+0.68 (+1.54%) ▲|WFC86.37-1.37 (-1.56%) ▼|WMT109.21-1.19 (-1.07%) ▼|XOM154.45+2.74 (+1.81%) ▲|AAPL323.85-3.89 (-1.19%) ▼|ABBV253.46-2.65 (-1.03%) ▼|ABT100.82+1.15 (+1.15%) ▲|ACN139.77-1.10 (-0.78%) ▼|ADBE220.19-6.98 (-3.07%) ▼|AMAT560.42-4.13 (-0.73%) ▼|AMD553.93+9.50 (+1.74%) ▲|AMGN367.44+1.20 (+0.33%) ▲|AMT166.14+2.75 (+1.68%) ▲|AMZN242.86-4.69 (-1.89%) ▼|AVGO396.13+9.63 (+2.49%) ▲|AXP348.86-1.94 (-0.55%) ▼|BA209.04+4.24 (+2.07%) ▲|BAC61.61+0.39 (+0.63%) ▲|BKNG179.21-0.19 (-0.11%) ▼|BLK1,044.79+6.55 (+0.63%) ▲|BMY60.84-0.10 (-0.16%) ▼|BNY159.81+0.92 (+0.58%) ▲|BRK-B489.28-0.37 (-0.08%) ▼|C132.83-0.01 (-0.01%) ▼|CAT898.25+8.28 (+0.93%) ▲|CL91.90+1.40 (+1.55%) ▲|CMCSA23.67-0.14 (-0.60%) ▼|COF201.62-4.60 (-2.23%) ▼|COP119.28+1.78 (+1.51%) ▲|COST924.51-4.72 (-0.51%) ▼|CRM162.70-7.36 (-4.33%) ▼|CSCO112.68+0.50 (+0.45%) ▲|CVS109.65-0.96 (-0.86%) ▼|CVX192.90+1.83 (+0.96%) ▲|DE608.21+21.33 (+3.63%) ▲|DHR177.48-1.53 (-0.85%) ▼|DIS96.47+0.33 (+0.34%) ▲|DUK127.86+1.95 (+1.55%) ▲|EMR139.90+0.64 (+0.46%) ▲|FDX319.12+3.93 (+1.25%) ▲|GD372.94+5.21 (+1.42%) ▲|GE341.95+1.25 (+0.37%) ▲|GEV993.30-85.51 (-7.93%) ▼|GILD131.50+1.22 (+0.94%) ▲|GM82.09+2.57 (+3.23%) ▲|GOOG345.87-0.32 (-0.09%) ▼|GOOGL346.53-0.62 (-0.18%) ▼|GS1,095.69+10.13 (+0.93%) ▲|HD332.81+1.21 (+0.36%) ▲|HON232.25+2.39 (+1.04%) ▲|IBM205.66-4.85 (-2.30%) ▼|INTC104.00-1.46 (-1.38%) ▼|INTU285.60-4.32 (-1.49%) ▼|ISRG343.74-6.33 (-1.81%) ▼|JNJ254.66+4.05 (+1.61%) ▲|JPM347.31+2.08 (+0.60%) ▲|KO82.55+0.58 (+0.70%) ▲|LIN510.57+5.54 (+1.10%) ▲|LLY1,163.58-11.84 (-1.01%) ▼|LMT516.18+9.09 (+1.79%) ▲|LOW204.00+1.74 (+0.86%) ▲|LRCX321.50-0.50 (-0.16%) ▼|MA533.26-5.04 (-0.94%) ▼|MCD264.20+0.29 (+0.11%) ▲|MDLZ60.82+0.96 (+1.60%) ▲|MDT81.82-0.54 (-0.65%) ▼|META626.35-17.46 (-2.71%) ▼|MMM170.45-0.32 (-0.18%) ▼|MO72.65-0.34 (-0.47%) ▼|MRK127.80+1.54 (+1.22%) ▲|MS218.35+1.95 (+0.90%) ▲|MSFT387.97-9.78 (-2.46%) ▼|MU971.29+0.47 (+0.05%) ▲|NEE89.60+1.67 (+1.90%) ▲|NFLX69.26+0.59 (+0.86%) ▲|NKE41.96-1.00 (-2.33%) ▼|NOW95.26-6.80 (-6.66%) ▼|NVDA213.69+6.40 (+3.09%) ▲|ORCL125.01-2.04 (-1.61%) ▼|PEP136.07+1.07 (+0.79%) ▲|PFE24.93-0.02 (-0.06%) ▼|PG149.76+1.66 (+1.12%) ▲|PLTR123.84-8.82 (-6.65%) ▼|PM192.80+4.76 (+2.53%) ▲|QCOM176.03+2.53 (+1.46%) ▲|RTX194.83+1.16 (+0.60%) ▲|SBUX104.17-0.28 (-0.27%) ▼|SCHW100.33+0.37 (+0.37%) ▲|SO95.54+1.69 (+1.80%) ▲|SPG226.82+0.03 (+0.01%) ▲|T23.03+0.77 (+3.44%) ▲|TMO524.26+0.80 (+0.15%) ▲|TMUS191.92+1.15 (+0.60%) ▲|TSLA375.83-3.11 (-0.82%) ▼|TXN294.06+2.76 (+0.95%) ▲|UBER70.45-1.10 (-1.54%) ▼|UNH434.68-1.67 (-0.38%) ▼|UNP293.46+0.33 (+0.11%) ▲|UPS116.44+0.10 (+0.09%) ▲|USB64.07+0.36 (+0.56%) ▲|V354.01-1.81 (-0.51%) ▼|VZ44.46+0.68 (+1.54%) ▲|WFC86.37-1.37 (-1.56%) ▼|WMT109.21-1.19 (-1.07%) ▼|XOM154.45+2.74 (+1.81%) ▲|
30.3 C
New York
Wednesday, July 22, 2026

Tag: surgery

Oncoinvent achieves 50% recruitment milestone in Phase 2 ovarian cancer study of Radspherin®

Strong recruitment momentum demonstrated in 2026 Year-to-date recruitment has already surpassed total enrollment for 2025OSLO, Norway, June 18, 2026 /PRNewswire/ -- Oncoinvent, a clinical-stage...

ZEISS Medical Technology and Aier Eye Hospital Group Sign Strategic Agreement for 25 VISUMAX 800 Units

JENA, Germany, June 18, 2026 /PRNewswire/ -- ZEISS Medical Technology announced today that the company held a signing ceremony with the Aier Eye Hospital...

My Derma Dream MyoGlow Examined 2026 – Why Is the MyoGlow Arm Device Getting So Much Attention Across the United States?

Miami, Florida, June 16, 2026 (GLOBE NEWSWIRE) --

There is a quiet conversation happening in fitting rooms, group texts, and medical offices all over the country that rarely surfaces publicly. It is about arms. More specifically, it is about the moment a woman picks up a sleeveless top, holds it against herself in the mirror, and puts it back on the rack. Not because the top is the wrong color or cut. Because she does not want her arms on display.

The Inner Circle acknowledges Haider Jaffrey, DDS as a Pinnacle Lifetime Member

MORGANTOWN, W.Va., June 15, 2026 /PRNewswire/ -- Prominently featured in The Inner Circle, Haider Jaffrey, DDS is acknowledged as a Pinnacle Lifetime Member for his...

DEPEND® AND DEION “COACH PRIME” SANDERS ENCOURAGE PROACTIVE CARE DURING MEN’S HEALTH MONTH

Coach Prime encourages men to get their annual physicals and shares words of encouragement as the new face of Depend Real Fit® packagingCHICAGO, June...

KFSH Demonstrates How Specialized Hospitals Can Drive Health System Innovation at HLTH Europe 2026

AMSTERDAM, June 15, 2026 (GLOBE NEWSWIRE) -- Through its sponsorship and participation at HLTH Europe 2026, taking place from June 15 to 18 in Amsterdam, King Faisal Specialist Hospital & Research Centre (KFSH) is demonstrating how specialized hospitals can become engines of health-system innovation by turning advanced science, digital infrastructure, and operational redesign into measurable improvements in care.

Cardiawave Announces First Routine Treatments Performed with Valvosoft® Following CE Mark Approval and Accelerates Its Deployment

Cardiawave Announces First Routine Treatments Performed with Valvosoft® Following CE Mark Approval and Accelerates Its Deployment

North Canyon Medical Center and All Access Hosted by Andy Garcia Highlight Rural Healthcare Infrastructure and Advanced Robotics

LOS ANGELES, June 15, 2026 /PRNewswire/ -- As rural medical facilities face increasing operational challenges, North Canyon Medical Center joins the award-winning series, "All...

Osstem Implant Accelerates Innovation in India with ‘Denall TV’, a Digital Dental Education Hub

Over the past two years since its launch in April 2024, Denall TV has become a core platform for digital dental education in India.Opened...

Crinetics Presents Full Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH) in Oral Presentation at ENDO 2026

Data show investigational atumelnant drove sustained androgen reductions while enabling lowering of glucocorticoid supplementation to physiologically normal levels in adults with classic CAH

Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control

Data from up to two years of treatment in PATHFNDR-1 and PATHFNDR-2 open-label extension studies show PALSONIFY maintained lower IGF-1 levels and stable symptoms

Orbis International’s Flying Eye Hospital Arrives in Peru to Expand Access to Essential Eye Care

With support from Alcon, FedEx, and OMEGA, the Orbis Flying Eye Hospital returns to Peru to carry out a training project in the city of Arequipa.AREQUIPA,...

Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2...

– Verekitug, administered once every three months, led to clinically meaningful improvements in nasal polyp score (NPS) in approximately 80% of participants –

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsSurgery